Target intelligence / Profile preview

Phosphoinositide-3-kinase regulatory subunit 3 (PIK3R3)

Target
PIK3R3
Molecular classification
Enzyme regulator (regulatory subunit), Lipid kinase regulatory subunit, Class IA phosphoinositide 3-kinase regulatory protein
01

Overview

Phosphoinositide-3-kinase regulatory subunit 3 (PIK3R3) encodes the p55 gamma regulatory subunit of the class IA phosphoinositide 3-kinase (PI3K) enzyme complex[2][5]. It binds to the p110 catalytic subunit and activated protein tyrosine kinases via its SH2 domains, regulating PI3K lipid kinase activity that is essential for producing PIP3 at the plasma membrane in response to extracellular signals. PIK3R3 is involved in signaling pathways that control cell growth, proliferation, survival, and metabolism. It is upregulated in several cancers and promotes tumor cell proliferation, potentially through mechanisms partly independent of classical Akt pathway activation[4][6]. PIK3R3 may be a novel therapeutic target, particularly in cancers exhibiting dysregulated PI3K pathway signaling. However, no selective drugs currently target PIK3R3 as a single agent.

Other names
p55 gammaphosphatidylinositol 3-kinase regulatory subunit gammaPI3-kinase regulatory subunit gammaPI3K regulatory subunit gammaPI3-kinase subunit p55-gammaPtdIns-3-kinase regulatory subunit p55-gammaphosphoinositide-3-kinase regulatory subunit gammap55PIKp55-GAMMA
02

Mechanism of action

PI3K inhibitors prevent production of phosphatidylinositol-3,4,5-trisphosphate (PIP3), blocking downstream signaling important for cell survival and proliferation[3][4]. Knockdown or inhibition induces G0/G1 cell cycle arrest and reduces cell proliferation[4][6].

03

Biological functions

Signal transductionCell proliferationCell survivalCell cycle progressionRegulation of metabolism
04

Disease associations

CancerInflammationCardiovascular diseaseMetabolic diseases
05

Safety considerations

On-target effects of PI3K inhibition can result in metabolic dysregulation (insulin resistance, hyperglycemia) and immune suppression[3].Targeting regulatory subunits could have unpredictable effects due to complex PI3K isoform signaling redundancy[5].
06

Interacting drugs

Evidence for direct drug targeting is limited; PI3K pathway inhibitors (such as LY294002) downregulate PIK3R3 expression indirectly[4].

1 more in the full profile.

07

Biomarkers

PIK3R3 expression can serve as a biomarker for cancer cell proliferation, particularly in gastric and other cancers[4][6].Regulatory subunit expression levels may stratify patients likely to benefit from PI3K pathway inhibition.

Beyond the preview

Go deeper on Phosphoinositide-3-kinase regulatory subunit 3 (PIK3R3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Phosphoinositide-3-kinase regulatory subunit 3 (PIK3R3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call